Briacell Therapeutics Corp (BCTX)
Notification from BriaCell Therapeutics Corp.
Travere Therapeutics, Inc (TVTX)
Travere Therapeutics Announces FDA Extends Review of sNDA for FILSPARI® (sparsentan) in FSGS
agilon health Inc (AGL)
Law Offices of Frank R. Cruz Encourages agilon health, inc. (AGL) Shareholders To Inquire About Securities Fraud Class Action
GENFIT S.A. (GNFT)
GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
agilon health Inc (AGL)
Law Offices of Howard G. Smith Encourages agilon health, inc. (AGL) Shareholders To Inquire About Securities Fraud Class Action
Coherent Inc (COHR)
Attalon Launches as Independent Defense Technology Leader; Appoints John Bergeron as CEO to Strengthen Leadership in Precision Optics and Directed Energy
Perrigo Company plc (PRGO)
Perrigo Company plc (PRGO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Agenus Inc. (AGEN)
La France étend laccès national à lAAC pour le botensilimab + balstilimab dAgenus contre le cancer de lovaire et les sarcomes des tissus mous
Agenus Inc. (AGEN)
Francia amplía el acceso nacional a la AAC para el botensilimab + balstilimab de Agenus para el cáncer de ovario y los sarcomas de tejidos blandos
Agenus Inc. (AGEN)
フランス、卵巣がんおよび軟部肉腫を対象に、アジーナスの「ボテンシリマブ＋バルスチリマブ」について国家レベルのAACアクセスを拡大